$ELTX Cashflow Statement | Understand Stock

$ELTX

$1.83 +$0.13 (7.65%) Close

$ELTX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation
Amortization of right-of-use assets, operating leases
Amortization of debt issuance costs
Non-cash placement agent fee
Amortization of debt discount
Non-cash interest expense
Costs expensed upon the issuance of warrants
Change in fair value of embedded derivative
Change in fair value of warrant liabilities
Impairment of leased assets
Losses from equity investment
Distribution from equity investment
Loss on issuance of warrants
Stock-based compensation
Change in fair value of convertible notes
Change in fair value of Series C convertible preferred stock
Non-cash professional services expense
Gain on disposal of property and equipment
Changes in operating assets and liabilities:
Grants receivable
Prepaid expenses and other current assets
Other long-term prepaid assets
Accounts payable
Accrued expenses
Deferred research obligation
Operating lease liability

Net cash used in operating activities
Cash flows from investing activities
Purchases of property and equipment
Proceeds from sale of property and equipment
Net cash used in investing activities
Cash flows from financing activities
Cash acquired in connection with the reverse merger
Merger transaction costs
Proceeds from the exercise of common stock warrants
Proceeds from June 2025 Promissory Note, net of issuance costs
Proceeds from issuance of Series C convertible preferred stock, net of issuance costs
Proceeds from loan from PPP
Proceeds from issuance of common stock warrants from March 2024 Offering
Proceeds from issuance of common stock warrants from July 2024 Public Offering
Proceeds from issuance of common stock from at-the-market offerings, net of issuance costs.
Proceeds from financing obligation
Proceeds from RSU settlement
Proceeds from RSU settlement, net of payment of taxes
Payment of financing obligation
Fractional share payments related to the forward stock split
Taxes paid related to net share settlement upon vesting of restricted stock awards
Exercise of broker warrants
Proceeds from issuance of common stock from July 2024 Public Offering
Payment of warrant issuance costs
Proceeds from issuance of Convertible Note, net of issuance costs
Payment of employee withholding taxes on restricted stock
Proceeds from issuance of common stock and common warrants from January 2025 Offering
Proceeds from exercise of stock options
Net cash provided by financing activities

Effect of foreign currency on cash
Net (decrease) increase in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash at the beginning of the year
Cash, cash equivalents and restricted cash at the end of the year
Supplemental disclosure of noncash investing and financing activities:
Cash paid for interest
Retirement of treasury stock
Conversion of convertible notes into stock
Series C
Common Stock
Conversion of Series C preferred stock to common stock upon IPO
Net exercise of warrants upon IPO
Issuance of broker warrants with Series C convertible preferred stock
Accrued interest premium for Series C convertible preferred stock
Right of use assets exchanged for operating lease liabilities
Convertible notes issued in receivable
Deferred offering costs in accrued expenses or accounts payable
Fixed assets purchased in accrued expenses or accounts payable
Loss on disposal of property and equipment
Fair value of pre-funded warrants at issuance date
Fair value of common warrants at issuance date
Accretion of promissory note discount from embedded derivative
Fair value of common warrants upon settlement
Accretion of promissory note to face value
Settlement of promissory notes payable
Fair value of common warrants issued with January 2025 Offering
Fair value of common warrants issued with June 2025 Promissory Note
Non-cash vesting of restricted common stock
Conversion of related-party senior note and interest into common stock
Accretion of convertible note discount from embedded derivative
Accretion of convertible note discount from issuance costs
Interest expense from convertible notes payable
Non-cash issuance of stock
Components of cash, cash equivalents and restricted cash:
Cash and cash equivalents
Restricted cash

Comments